These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34972158)
1. MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy. Possamaï D; Hanafi LA; Bellemare-Pelletier A; Hamelin K; Thébault P; Hébert MJ; Gagnon É; Leclerc D; Lapointe R PLoS One; 2021; 16(12):e0261987. PubMed ID: 34972158 [TBL] [Abstract][Full Text] [Related]
2. Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells. Leclerc D; Beauseigle D; Denis J; Morin H; Paré C; Lamarre A; Lapointe R J Virol; 2007 Feb; 81(3):1319-26. PubMed ID: 17121795 [TBL] [Abstract][Full Text] [Related]
3. Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP. Babin C; Majeau N; Leclerc D J Nanobiotechnology; 2013 Apr; 11():10. PubMed ID: 23556511 [TBL] [Abstract][Full Text] [Related]
4. Role of autophagy in MHC class I-restricted antigen presentation. Van Kaer L; Parekh VV; Postoak JL; Wu L Mol Immunol; 2019 Sep; 113():2-5. PubMed ID: 29126597 [TBL] [Abstract][Full Text] [Related]
5. Alternative pathways for MHC class I presentation: a new function for autophagy. Chemali M; Radtke K; Desjardins M; English L Cell Mol Life Sci; 2011 May; 68(9):1533-41. PubMed ID: 21390546 [TBL] [Abstract][Full Text] [Related]
6. Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899 [TBL] [Abstract][Full Text] [Related]
7. Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells. Dasari V; Rehan S; Tey SK; Smyth MJ; Smith C; Khanna R Immunol Cell Biol; 2016 Nov; 94(10):964-974. PubMed ID: 27297581 [TBL] [Abstract][Full Text] [Related]
8. Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes. Hanafi LA; Bolduc M; Gagné ME; Dufour F; Langelier Y; Boulassel MR; Routy JP; Leclerc D; Lapointe R Vaccine; 2010 Aug; 28(34):5617-26. PubMed ID: 20600515 [TBL] [Abstract][Full Text] [Related]
9. A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling. Thérien A; Bédard M; Carignan D; Rioux G; Gauthier-Landry L; Laliberté-Gagné MÈ; Bolduc M; Savard P; Leclerc D J Nanobiotechnology; 2017 Jul; 15(1):54. PubMed ID: 28720097 [TBL] [Abstract][Full Text] [Related]
10. Autophagy and MHC-restricted antigen presentation. Valečka J; Almeida CR; Su B; Pierre P; Gatti E Mol Immunol; 2018 Jul; 99():163-170. PubMed ID: 29787980 [TBL] [Abstract][Full Text] [Related]
11. Cross-presentation: underlying mechanisms and role in immune surveillance. Rock KL; Shen L Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335 [TBL] [Abstract][Full Text] [Related]
12. The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation. Grotzke JE; Sengupta D; Lu Q; Cresswell P Curr Opin Immunol; 2017 Jun; 46():89-96. PubMed ID: 28528219 [TBL] [Abstract][Full Text] [Related]
13. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. Zhang QJ; Li XL; Wang D; Huang XC; Mathis JM; Duan WM; Knight D; Shi R; Glass J; Zhang DQ; Eisenbach L; Jefferies WA PLoS One; 2008 Aug; 3(8):e3097. PubMed ID: 18769733 [TBL] [Abstract][Full Text] [Related]
14. Involvement of autophagy in MHC class I antigen presentation. Øynebråten I Scand J Immunol; 2020 Nov; 92(5):e12978. PubMed ID: 32969499 [TBL] [Abstract][Full Text] [Related]
15. Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery. Robson NC; McAlpine T; Knights AJ; Schnurr M; Shin A; Chen W; Maraskovsky E; Cebon J Blood; 2010 Jul; 116(2):218-25. PubMed ID: 20430956 [TBL] [Abstract][Full Text] [Related]
16. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. Win SJ; Ward VK; Dunbar PR; Young SL; Baird MA Immunol Cell Biol; 2011 Aug; 89(6):681-8. PubMed ID: 21221122 [TBL] [Abstract][Full Text] [Related]
17. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903 [TBL] [Abstract][Full Text] [Related]
18. Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis. Hari A; Ganguly A; Mu L; Davis SP; Stenner MD; Lam R; Munro F; Namet I; Alghamdi E; Fürstenhaupt T; Dong W; Detampel P; Shen LJ; Amrein MW; Yates RM; Shi Y Eur J Immunol; 2015 Feb; 45(2):383-95. PubMed ID: 25378230 [TBL] [Abstract][Full Text] [Related]
19. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476 [TBL] [Abstract][Full Text] [Related]
20. Impact of the TAP-like transporter in antigen presentation and phagosome maturation. Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]